Critical Reviews in Clinical Laboratory Sciences

Critical Reviews in Clinical Laboratory Sciences 由 Informa Healthcare 出版，属中科院医学大类（2025 升级版2区）。按 OpenAlex 近年发文统计，该刊主要发表 Clinical Laboratory Practices and Quality Control、Meta-analysis and systematic reviews、Cancer Genomics and Diagnostics 等主题的论文，这 3 个主题约占 25.7%。（根据 OpenAlex 主题统计与中科院分区数据生成）

Aims and scopeJournal metrics Editorial board Critical Reviews in Clinical Laboratory Sciences publishes comprehensive and high quality review articles in all areas of clinical laboratory science, including clinical biochemistry, hematology, microbiology, pathology, transfusion medicine, genetics, immunology and molecular diagnostics. The reviews critically evaluate the status of current issues in the selected areas, with a focus on clinical laboratory diagnostics and latest advances. The adjective “critical” implies a balanced synthesis of results and conclusions that are frequently contradictory and controversial. Our aim is to meet the needs of and build a bridge between two constituencies: to allow clinical scientists to broaden their knowledge base to include the vocabulary, concepts, and information from the various fields of medicine that they require to perform their work; and to allow laboratory physicians to keep pace with the rapid developments taking place in scientific disciplines that directly impact their daily activities. The articles in this journal are accessible to a broad/non-specialist audience, in addition to the constituencies highlighted above. Therefore, introductory material should be included in each article to allow a non-specialist reader to understand the text that follows. The scope includes the clinical laboratory aspects of detection, prevention, diagnosis, monitoring, prognosis, and management of disease, including cancer and metabolic disease; biochemistry, genetics and immunobiology of disease; biomarkers and their application; genomic and proteomic approaches; and trends in clinical laboratory diagnostics. Reviews are generally solicited from international experts on the advice of members of the Editorial Advisory Board. However, other authors are encouraged to submit outlines of proposed reviews to the Editor-in-Chief for consideration, following which a formal invitation may be issued. Authors are recommended to recruit collaborators to help in forging a representative consensus and comprehensive coverage of the selected topic. Peer Review Policy: Two or more reviewers/editorial board members, with appropriate expertise in the field but no conflicts of interest, are assigned to referee each manuscript. Read full aims and scope

摘自期刊官网 Aims & Scope

研究方向（LetPub）：医学-医学实验技术

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

6.2LetPub · 2026-09-13

CiteScore 2026-06

12.8LetPub · 2026-09-13

SJR 2026-06

1.65LetPub · 2026-09-13

SNIP 2026-06

2.14LetPub · 2026-09-13

h-index

66LetPub · 2026-09-13

h-index

118OpenAlex · 2026-10-01

i10-index

588OpenAlex · 2026-10-01

两年平均被引

6.52OpenAlex · 2026-10-01

自引率

3.2%LetPub · 2026-09-13

Gold OA 文章占比

18.1%LetPub · 2026-09-13

发文规模

年文章数

47LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

>12周，或约稿LetPub · 2026-09-13

平均录用比例（社区反馈）

较难LetPub · 2026-09-13

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

尚未从任何来源获得费用信息，请以期刊官网为准。

混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

Informa Healthcare

出版国家或地区

UNITED STATES

出版语言

English

出版周期

Bimonthly

创刊年份

1980

ISSN

1040-8363

电子版 ISSN

1549-781X

官网最新一期

Volume 63, Issue 6（2026 年）

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗出版商官网
• 专刊 / 特刊征稿 ↗出版商官网